Psyence Biomedical (PBM) Net Equity Issued and Repurchased (2023)
Psyence Biomedical (PBM) posted Net Equity Issued and Repurchased of -$247.4 million for Q3 2023.
Powered by 
Analysis
Psyence Biomedical (PBM) Net Equity Issued and Repurchased (2023) Analysis & Trends
Psyence Biomedical has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at -$247.4 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.47 Bn | 193.48 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.76 Bn | 175.58 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 61.10 Bn | 55.91 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.44 Bn | 48.30 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.55 Bn | 30.24 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.67 Bn | 30.39 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.63 Bn | 29.63 Bn | 1.16 Mn | - |
| 10 | Psyence Biomedical | 2.63 Mn | 2.63 Mn | - | - |